These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6782797

  • 1. Chronic myeloproliferative disorders: a quantitative assessment of platelet ultrastructure.
    Boughton BJ, Jerrome DW, Rychetnik M.
    Acta Haematol; 1980; 64(6):319. PubMed ID: 6782797
    [Abstract] [Full Text] [Related]

  • 2. Platelet abnormalities in myeloproliferative disorders.
    Holme S, Murphy S.
    Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Platelet function after busulphan in chronic myeloproliferative disorders.
    Barbui T, Bassan R, Viero P, Cortelazzo S, Dini E.
    Haematologica; 1983 Dec; 68(4):469-77. PubMed ID: 6414897
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Static and functional morphology of the pathological platelets in primary myelofibrosis and myeloproliferative syndrome.
    Hattori A, Koike K, Ito S, Matsuoka M.
    Ser Haematol; 1975 Dec; 8(1):126-50. PubMed ID: 1129598
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
    Cortelazzo S, Barbui T, Bassan R, Dini E.
    Thromb Haemost; 1980 Jun 18; 43(2):127-30. PubMed ID: 7455970
    [Abstract] [Full Text] [Related]

  • 10. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time.
    Baker RI, Manoharan A.
    Eur J Haematol; 1988 Mar 18; 40(3):267-72. PubMed ID: 3356243
    [Abstract] [Full Text] [Related]

  • 11. Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: deficiency of an aspirin-independent mechanism?
    Viero P, Cortelazzo S, Barbui T, de Gaetano G.
    Haemostasis; 1986 Mar 18; 16(1):27-33. PubMed ID: 3699584
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of the response to acetylsalicylic acid in patients with myeloproliferative neoplasms by whole blood assays: a comparison of the PFA-100 with multiple electrode aggregometry.
    Robier C, Neubauer M, Quehenberger F, Stettin M, Neumeister P.
    Platelets; 2014 Mar 18; 25(8):608-11. PubMed ID: 24245548
    [Abstract] [Full Text] [Related]

  • 14. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
    Boughton BJ, Allington MJ, King A.
    Br J Haematol; 1978 Sep 18; 40(1):125-32. PubMed ID: 81681
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The ultrastructure of the platelets in refractory anemia ("preleukemia") and myelomonocytic leukemia.
    Maldonado JE.
    Ser Haematol; 1975 Sep 18; 8(1):101-25. PubMed ID: 48277
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders.
    Nishimura J, Okamoto S, Ibayashi H.
    Thromb Haemost; 1979 Jun 30; 41(4):787-95. PubMed ID: 483250
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.